Aralen Articles
Pfizer in deal to market Eurartesim in Africa
15 December 2008
Global Fund malaria drug scheme could fail
17 November 2008
"One in three" malaria drugs in Africa fail
19 May 2008
WHO urges access to new antimalarials
3 May 2004
WHO and Global Fund slammed over drugs
26 January 2004
WHO steps up action against substandard and counterfeit medicines
24 November 2003
India revises 22 bulk drug prices
2 June 2003
India cuts malaria drug prices, raises others
14 April 2003
Bayer takes awards for tropical medicines
27 May 2002
Burundi acts on drug-resistant malaria
27 June 2001
Novartis/WHO sign malaria drug deal
28 May 2001
Zyban safety fears resurface in UK
27 April 2001
Chloroquine resistance to malaria in Uganda
16 October 2000
Indian malaria, asthma/ allergy price moves
10 October 2000
India's NPPA reduces five bulk drug prices
20 July 2000
Dumping causes key Indian bulk drug prices to plunge
12 November 1999
Kenya's Dawa Pharmaceuticals defends quality of Dawaquin
21 January 1999
Bayer AG Setting Up Indian Joint Venture
3 July 1998
Biotech Promise For Rheumatoid Arthritis
26 February 1998
Chloroquine Import Curbs Cause More Deaths In Uganda
25 July 1997
R-PR's "Essential" Anti-Malarial Treatment
22 July 1996
Japanese Drug Law "Failed To Stop HIV Tragedy"
8 April 1996
Pharma Mar's Ocean Therapeutics Get An Airing
2 October 1995
NOVEL ANTIMALARIAL R&D IN AUSTRALIA
16 August 1993
DRUG COMPANIES FAILING TO TARGET MALARIA?
9 November 1992
MALARIA TREATMENT NEEDS IMPROVING
6 July 1992
ZIMBABWE; PATIENT INFORMATION STUDY
27 January 1992
MALARIA DRUG RESEARCH ADVANCE
13 January 1992
Showing 1-32 of 32 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
